Insight

Are high-dose steroids for immunotherapy-related toxicity harmful in the long run?

Photo of Rik J. Verheijden from research.umcutrecht.nl

Aug 11, 2024, 12:51

Are high-dose steroids for immunotherapy-related toxicity harmful in the long run?

Peter Lau, Specialist Physician in Medical Oncology at Hollywood Private Hospital, shared a paper by Rik J. Verheijden et al. on X:

“Are high-dose steroids for immunotherapy-related toxicity harmful in the long run? This paper suggests they are for cancer. But was the dose of the steroid proportionate to the severity of the IO toxicity?”

Source: Peter Lau/X

steroids

Authors: Rik J. Verheijden, Jolien S. de Groot, Babs O. Fabriek, Miki N. Hew, Anne M. May, Karijn P.M. Suijkerbuijk

Corticosteroids for Immune-Related Adverse Events and Checkpoint Inhibitor Efficacy: Analysis of Six Clinical Trials

Anne M. May Babs O. Fabriek cancer immunotherapy-related toxicity Jolien S. de Groot Karijn P.M. Suijkerbuijk Miki N. Hew OncoDaily Oncology Peter Lau Rik J. Verheijden Steroids

New Paper Alert: Systemic management of advanced HCC: an increasingly complex game

AC-satoreotide got FDA Orphan Drug Designation status for SCLC and MCC

Oncologist Near Me – Nazik Hammad: A Leader in Cancer Care, Medical Education, and Health Equity

Garo Armen - A Bold Call to Action: Embracing Real-Time Innovation in Pediatric Cancer

Black History Month 2025: Honoring Contributions to Oncology